Doctors of Meenakshi Mission Hospital has successfully used monoclonal antibody therapy to treat Anti-Glomerular Basement Membrane disease, helping a patient recover kidney function and come off ...

First-in-human study underway evaluating anti-CD36 monoclonal antibody designed to restore metabolic fitness in exhausted T cells, reduce immunosuppressive cells, and enhance antitumor immunity Pilatu ...

Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy1 ...

In the rapidly shifting landscape of multiple myeloma treatment, the roadmap for a patient diagnosed in 2026 looks vastly different than it did even a decade ago. In a recent interview with CURE, Dr.

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to autoimmune disease therapy. However, during manufacturing, storage, or ...

The study published on March 11 shows that children with severe E. coli infections receive significantly less protective antibodies before birth.

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsJennie WillsonJacqueline Shea - CEO, President ...

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Today, advancements in medicine have rendered HIV a manageable condition that allows most individuals to enjoy a typical lifespan. What it often takes to achieve that level of longevity, however, is ...

Current treatments focus on controlling inflammation and minimizing long-term damage. Learn more.

While the strategies didn’t lower NT-proBNP after PCI in acute MI patients, they may suggest a way forward for intervening early.

Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative dual payload bispecific antibody-drug conjugate ...